[
  {
    "ts": null,
    "headline": "Biogen Inc. stock underperforms Tuesday when compared to competitors",
    "summary": "Biogen Inc. stock underperforms Tuesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=0285ff261bc9b409d38e02fd93bbec9707a81d2537ef538062e90561e79e5b68",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752599220,
      "headline": "Biogen Inc. stock underperforms Tuesday when compared to competitors",
      "id": 135989070,
      "image": "",
      "related": "BIIB",
      "source": "MarketWatch",
      "summary": "Biogen Inc. stock underperforms Tuesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=0285ff261bc9b409d38e02fd93bbec9707a81d2537ef538062e90561e79e5b68"
    }
  },
  {
    "ts": null,
    "headline": "Draig Therapeutics Appoints Experienced Biotech Leader Douglas E. Williams, Ph.D. as Chair of its Board of Directors",
    "summary": "Douglas E. Williams, Ph.D. Chair of the Board of Directors Strong track record at executive and board level of building company value across all stages of development including supporting the development of multiple blockbuster medicines Cardiff, United Kingdom – 15 July 2025 – Draig Therapeutics (“Draig”), a clinical-stage company aiming to transform the treatment of neuropsychiatric diseases, today announces the appointment of Douglas E. Williams, Ph.D. as independent Chair of its Board of Dir",
    "url": "https://finnhub.io/api/news?id=cb0b56daaf668d75e90470e4d439c0e843a6615f148fefabf85074f7ee81ecdc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752566400,
      "headline": "Draig Therapeutics Appoints Experienced Biotech Leader Douglas E. Williams, Ph.D. as Chair of its Board of Directors",
      "id": 135937062,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BIIB",
      "source": "Yahoo",
      "summary": "Douglas E. Williams, Ph.D. Chair of the Board of Directors Strong track record at executive and board level of building company value across all stages of development including supporting the development of multiple blockbuster medicines Cardiff, United Kingdom – 15 July 2025 – Draig Therapeutics (“Draig”), a clinical-stage company aiming to transform the treatment of neuropsychiatric diseases, today announces the appointment of Douglas E. Williams, Ph.D. as independent Chair of its Board of Dir",
      "url": "https://finnhub.io/api/news?id=cb0b56daaf668d75e90470e4d439c0e843a6615f148fefabf85074f7ee81ecdc"
    }
  }
]